healthcarereimagined

Envisioning healthcare for the 21st century

  • About
  • Economics

The Future of Medicine Is in Your Poop – NIST

Posted by timmreardon on 05/15/2024
Posted in: Uncategorized.

In the fall of 2023, NIST’s scientists in Charleston, South Carolina, received a special shipment of containers packed with baggies full of frozen human feces.

Teams of scientists there and at an outside lab worked together to grind the material into fine dust and blend it with water until it had the consistency of a smoothie. It was then poured into 10,000 tubes and distributed among NIST’s staff in Charleston and Gaithersburg, Maryland.

Scientists in both cities have been rigorously analyzing and studying the waste-matter mixture ever since.

All this excretory experimentation is helping to lay the groundwork for a new generation of treatments and medicines derived from human feces.

The power of poop comes from the microbes it contains. They are a rich sampling of the trillions of microbes living inside our gut, all part of the gut microbiome. In the last decade, scientists have linked the gut microbiome to a raft of human diseases, including inflammatory bowel disease, bacterial infections, autoimmune disorders, obesity and even cancer and mental illness.

Isolating fecal microbes and then turning them into therapies may be a way to treat many of these diseases. In fact, the FDA has recently approved two drugs for treating recurring bacterial infections, both of which are derived from highly processed human stool samples.

“This isn’t just wishful thinking. It’s already happening,” said NIST molecular geneticist Scott Jackson. “We are at the beginning of a new era of medicine.”

Why Poop?

Scott Jackson wears safety glasses and a lab coat as he looks up a two petri dishes he is holding.
Scott Jackson has spearheaded NIST’s efforts to develop a fecal reference material.Credit: R. Wilson/NIST

While human feces also contain water, undigested food and assorted inorganic matter, anywhere from 30% to 50% is made up of bacteria, viruses, fungi and other organisms that once lived in our guts.

We could not survive without these fellow travelers. They play a critical role in metabolism, vitamin production and digestion. By regulating the immune system, they help ward off harmful bacteria and toxins.

Their activity also impacts the nervous system via the gut-brain connection, affecting mood and mental health and influencing many neurological conditions, including Alzheimer’s and autism.

We are only beginning to understand the relationship between microbes and diseases. We have significant gaps in our knowledge about how microbes affect other systems and processes in the body. And certainly, just because changes in the gut microbiome correlate with a particular disease doesn’t mean they cause it.

Still, it’s clear that the signals gut microbes send to each other and cells elsewhere in the body significantly impact our health.

Doctors could get a sample of your microbiome directly from your gut, but that means undergoing an invasive procedure like a colonoscopy or biopsy.

Getting a specimen of stool is (ironically) less messy.

“Fecal material is convenient,” Jackson said. “Everybody poops.”

But Really, Poop Medicine?

Everyone’s stool is different. The amount and types of microorganisms vary based on your genes, environment, health and diet. But scientists have discerned similarities in the poop of individuals with certain diseases. People with Parkinson’s disease, for example, show both higher and lower concentrations of certain bacterial species. For people with asthma, poop has reduced levels of microbial diversity.

These correlations, some quite clear and others still unclear, may make it possible to use stool samples to diagnose a wide range of illnesses and conditions. You’d send a fecal sample to a lab, which would then identify the microorganisms in it by decoding, or “sequencing,” their DNA.

Jackson said the results could be used to not only diagnose certain illnesses but also evaluate the risk of getting the illnesses in the future.

“We would analyze microbial DNA in stool for the same reason we test human DNA — to tell us about your risk of disease,” he said.

Beyond their use in diagnosing diseases, could feces-derived microbes be used to treat them?

This is actually already happening.

Fecal microbiota transplants (FMTs) are now used to treat recurrent Clostridioides difficile infection (CDI), a sometimes-deadly bacterial infection commonly picked up in hospitals. FMT is like any other kind of transplant, though in this case, it’s someone else’s fecal matter that’s transferred into the sick patient.

The microorganisms from the transplant help regenerate the healthy ecosystem in the gut microbiome, assisting the immune system to fight off the infection. On recurrent CDI, the procedure has a success rate of 95%, a remarkable result for just about any therapy.

Research into other uses for FMT is exploding. According to clinicaltrials.gov, there are dozens of studies in the United States right now involving FMT, with clinicians and researchers testing it out on everything from cancer to colitis to alcoholic hepatitis.

Researchers are also exploring alternative approaches that involve genetically modifying fecal bacteria, creating disease-fighting microbes that would take root in your gut and help restore the microbiome to full health. There’s even the possibility of altering your own fecal microbes, a personalized medicine approach that customizes the therapy to the individual patient.

In addition to the gut microbiome, there are multitudes of microorganisms in the nose, skin, throat and vagina, all part of what’s known as the human microbiome.

Jackson said that the next generation of microbial medicines will be derived from all over the human microbiome. They will be much more scientifically proven and effective for treating diseases than today’s probiotics, which are bacteria derived from fermented foods and categorized as dietary supplements.

“If things keep going the way they are now, I think in  30 years, medical doctors will have an arsenal of new microbial therapies to treat a broad spectrum of diseases,” Jackson said.

What’s NIST’s Role in All This?

Two researchers wearing protective gear are cutting open a bag labeled "Omnivore 1" over an icy freezer container.
NIST researchers handling frozen stool samples in Charleston. Credit: T. Schock/NIST

NIST produces reference materials (RMs) that help laboratories and manufacturers calibrate their instruments.

For example, the agency sells peanut butter that comes with a detailed analysis and measurements of its compounds and chemicals. Food companies need to know how much fat is in their products. To ensure they are measuring the amount correctly, they can perform tests on NIST’s peanut butter. If they get the same result as NIST, they know their equipment is accurate.

Having widely trusted and accepted reference materials, especially for complex materials, ensures quality control and accuracy across entire industries and research fields.

NIST is now developing an RM for human feces, officially called the Human Gut Microbiome (Whole Stool) Reference Material. NIST’s peanut butter lists its amount of calcium, copper, tetradecanoic acid and many other components. Similarly, the new RM, expected to be released this year, will itemize and describe the ingredients in feces.  

It will identify hundreds of species of microorganisms and detail the concentration of thousands of different metabolites in the gut, many of which are produced by microorganisms and help to convert nutrients into energy or synthesize molecules for cellular functions.

Other ingredients listed include many compounds you might not even have known were in feces: cholesterol (a type of metabolite), for example, and serotonin, most of which is found in the cells lining the gastrointestinal tract.

The RM aims to become the gold standard in human gut microbiome research and drug development. A single unit of the RM will consist of a milliliter tube filled with slurry fecal matter accompanied by a lengthy report that labs can use to check their measurements and fine-tune their instruments.

Many scientists believe a reference material for feces is desperately needed. Right now, “If you give two different laboratories the same stool sample for analysis, you’ll likely get strikingly different results,” Jackson said. Many discrepancies arise from the different protocols and tools the labs use. Others are the result of differing standards and definitions.

“NIST’s RM will help researchers develop, benchmark and harmonize their measurements,” Jackson said. “It’s the most detailed and comprehensive microbiological and biochemical breakdowns ever produced for human feces.” 

Article link: https://www.nist.gov/health/future-medicine-your-poop

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
Like Loading...

Related

Posts navigation

← What’s next in chips – MIT Technology Review
Army changing the color of money used to modernize software – Federal News Network →
  • Search site

  • Follow healthcarereimagined on WordPress.com
  • Recent Posts

    • Hype Correction – MIT Technology Review 12/15/2025
    • Semantic Collapse – NeurIPS 2025 12/12/2025
    • The arrhythmia of our current age – MIT Technology Review 12/11/2025
    • AI: The Metabolic Mirage 12/09/2025
    • When it all comes crashing down: The aftermath of the AI boom – Bulletin of the Atomic Scientists 12/05/2025
    • Why Digital Transformation—And AI—Demands Systems Thinking – Forbes 12/02/2025
    • How artificial intelligence impacts the US labor market – MIT Sloan 12/01/2025
    • Will quantum computing be chemistry’s next AI? 12/01/2025
    • Ontology is having its moment. 11/28/2025
    • Disconnected Systems Lead to Disconnected Care 11/26/2025
  • Categories

    • Accountable Care Organizations
    • ACOs
    • AHRQ
    • American Board of Internal Medicine
    • Big Data
    • Blue Button
    • Board Certification
    • Cancer Treatment
    • Data Science
    • Digital Services Playbook
    • DoD
    • EHR Interoperability
    • EHR Usability
    • Emergency Medicine
    • FDA
    • FDASIA
    • GAO Reports
    • Genetic Data
    • Genetic Research
    • Genomic Data
    • Global Standards
    • Health Care Costs
    • Health Care Economics
    • Health IT adoption
    • Health Outcomes
    • Healthcare Delivery
    • Healthcare Informatics
    • Healthcare Outcomes
    • Healthcare Security
    • Helathcare Delivery
    • HHS
    • HIPAA
    • ICD-10
    • Innovation
    • Integrated Electronic Health Records
    • IT Acquisition
    • JASONS
    • Lab Report Access
    • Military Health System Reform
    • Mobile Health
    • Mobile Healthcare
    • National Health IT System
    • NSF
    • ONC Reports to Congress
    • Oncology
    • Open Data
    • Patient Centered Medical Home
    • Patient Portals
    • PCMH
    • Precision Medicine
    • Primary Care
    • Public Health
    • Quadruple Aim
    • Quality Measures
    • Rehab Medicine
    • TechFAR Handbook
    • Triple Aim
    • U.S. Air Force Medicine
    • U.S. Army
    • U.S. Army Medicine
    • U.S. Navy Medicine
    • U.S. Surgeon General
    • Uncategorized
    • Value-based Care
    • Veterans Affairs
    • Warrior Transistion Units
    • XPRIZE
  • Archives

    • December 2025 (8)
    • November 2025 (9)
    • October 2025 (10)
    • September 2025 (4)
    • August 2025 (7)
    • July 2025 (2)
    • June 2025 (9)
    • May 2025 (4)
    • April 2025 (11)
    • March 2025 (11)
    • February 2025 (10)
    • January 2025 (12)
    • December 2024 (12)
    • November 2024 (7)
    • October 2024 (5)
    • September 2024 (9)
    • August 2024 (10)
    • July 2024 (13)
    • June 2024 (18)
    • May 2024 (10)
    • April 2024 (19)
    • March 2024 (35)
    • February 2024 (23)
    • January 2024 (16)
    • December 2023 (22)
    • November 2023 (38)
    • October 2023 (24)
    • September 2023 (24)
    • August 2023 (34)
    • July 2023 (33)
    • June 2023 (30)
    • May 2023 (35)
    • April 2023 (30)
    • March 2023 (30)
    • February 2023 (15)
    • January 2023 (17)
    • December 2022 (10)
    • November 2022 (7)
    • October 2022 (22)
    • September 2022 (16)
    • August 2022 (33)
    • July 2022 (28)
    • June 2022 (42)
    • May 2022 (53)
    • April 2022 (35)
    • March 2022 (37)
    • February 2022 (21)
    • January 2022 (28)
    • December 2021 (23)
    • November 2021 (12)
    • October 2021 (10)
    • September 2021 (4)
    • August 2021 (4)
    • July 2021 (4)
    • May 2021 (3)
    • April 2021 (1)
    • March 2021 (2)
    • February 2021 (1)
    • January 2021 (4)
    • December 2020 (7)
    • November 2020 (2)
    • October 2020 (4)
    • September 2020 (7)
    • August 2020 (11)
    • July 2020 (3)
    • June 2020 (5)
    • April 2020 (3)
    • March 2020 (1)
    • February 2020 (1)
    • January 2020 (2)
    • December 2019 (2)
    • November 2019 (1)
    • September 2019 (4)
    • August 2019 (3)
    • July 2019 (5)
    • June 2019 (10)
    • May 2019 (8)
    • April 2019 (6)
    • March 2019 (7)
    • February 2019 (17)
    • January 2019 (14)
    • December 2018 (10)
    • November 2018 (20)
    • October 2018 (14)
    • September 2018 (27)
    • August 2018 (19)
    • July 2018 (16)
    • June 2018 (18)
    • May 2018 (28)
    • April 2018 (3)
    • March 2018 (11)
    • February 2018 (5)
    • January 2018 (10)
    • December 2017 (20)
    • November 2017 (30)
    • October 2017 (33)
    • September 2017 (11)
    • August 2017 (13)
    • July 2017 (9)
    • June 2017 (8)
    • May 2017 (9)
    • April 2017 (4)
    • March 2017 (12)
    • December 2016 (3)
    • September 2016 (4)
    • August 2016 (1)
    • July 2016 (7)
    • June 2016 (7)
    • April 2016 (4)
    • March 2016 (7)
    • February 2016 (1)
    • January 2016 (3)
    • November 2015 (3)
    • October 2015 (2)
    • September 2015 (9)
    • August 2015 (6)
    • June 2015 (5)
    • May 2015 (6)
    • April 2015 (3)
    • March 2015 (16)
    • February 2015 (10)
    • January 2015 (16)
    • December 2014 (9)
    • November 2014 (7)
    • October 2014 (21)
    • September 2014 (8)
    • August 2014 (9)
    • July 2014 (7)
    • June 2014 (5)
    • May 2014 (8)
    • April 2014 (19)
    • March 2014 (8)
    • February 2014 (9)
    • January 2014 (31)
    • December 2013 (23)
    • November 2013 (48)
    • October 2013 (25)
  • Tags

    Business Defense Department Department of Veterans Affairs EHealth EHR Electronic health record Food and Drug Administration Health Health informatics Health Information Exchange Health information technology Health system HIE Hospital IBM Mayo Clinic Medicare Medicine Military Health System Patient Patient portal Patient Protection and Affordable Care Act United States United States Department of Defense United States Department of Veterans Affairs
  • Upcoming Events

Blog at WordPress.com.
  • Reblog
  • Subscribe Subscribed
    • healthcarereimagined
    • Join 154 other subscribers
    • Already have a WordPress.com account? Log in now.
    • healthcarereimagined
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d